DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2004

Amended Announcements
Please refer to the earlier announcement reference number: CS-041123-63600

DUOPHARMA BIOTECH BHD

Quarterly report for the financial period ended

30/09/2004
Quarter3
Financial Year End31/12/2004
The figureshave not been audited

Attachments

DBIOTEC-Q3 2004 BURSA-Amend.xls
92 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2004


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/09/2004 
30/09/2003 
30/09/2004 
30/09/2003 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
18,534
18,057
58,036
57,839
2Profit/(loss) before tax
6,166
5,839
20,241
17,931
3Profit/(loss)
after tax and minority
interest
5,353
4,325
16,902
13,242
4Net profit/(loss) for
the period
5,353
4,325
16,902
13,242
5Basic earnings/(loss) per share (sen)
4.06
3.28
12.80
10.03
6Dividend per share (sen)
0.00
0.00
3.00
5.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net tangible assets per share (RM)

0.7400
1.4500

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
Please note that amendments have been made to the following in respect of the 3rd Quarterly Results of year 2004 of the Company:-

(1) Net tangible assets per share should be RM0.74 and RM1.45 for the current quarter ended 30 September 2004 and preceding financial year ended 31 December 2003 respectively instead of RM74.00 and RM145.00 respectively.

(2) Comparative figure for the Unaudited Condensed Consolidated Cash Flow Statement for the period ended 30 September 2004 appearing in the last column should be 30 September 2003 instead of 31 December 2003

Announcement Info

Company NameDUOPHARMA BIOTECH BHD  
Stock Name DBIOTEC    
Date Announced29 Dec 2004  
CategoryFinancial Results
Reference NoCS-041228-53359

View original report